Achmea Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,169
Closed -$303K 428
2023
Q4
$303K Sell
1,169
-21,733
-95% -$5.34M 0.01% 474
2023
Q3
$5.89M Sell
22,902
-961
-4% -$257K 0.13% 180
2023
Q2
$6.8M Buy
23,863
+2,473
+12% +$736K 0.14% 160
2023
Q1
$5.95M Buy
21,390
+2,884
+16% +$798K 0.17% 146
2022
Q4
$4.8M Buy
18,506
+9,534
+106% +$2.69M 0.16% 159
2022
Q3
$2.4M Buy
8,972
+232
+3% +$49.3K 0.08% 246
2022
Q2
$1.78M Hold
8,740
0.06% 302
2022
Q1
$1.84M Buy
8,740
+258
+3% +$56.1K 0.05% 346
2021
Q4
$2.03M Sell
8,482
-1,002
-11% -$258K 0.1% 189
2021
Q3
$2.68M Sell
9,484
-1,518
-14% -$498K 0.08% 286
2021
Q2
$3.81M Sell
11,002
-7,495
-41% -$2.27M 0.13% 215
2021
Q1
$5.17M Sell
18,497
-3,834
-17% -$1.03M 0.18% 158
2020
Q4
$5.47M Sell
22,331
-16,164
-42% -$4.17M 0.2% 141
2020
Q3
$10.9M Sell
38,495
-46,957
-55% -$13.1M 0.46% 45
2020
Q2
$22.9M Buy
85,452
+19,522
+30% +$5.87M 0.77% 28
2020
Q1
$20.9M Buy
65,930
+45,585
+224% +$13.8M 0.96% 19
2019
Q4
$6.04M Sell
20,345
-9,535
-32% -$2.65M 0.23% 106
2019
Q3
$6.96M Sell
29,880
-3,551
-11% -$827K 0.27% 92
2019
Q2
$7.82M Buy
33,431
+6,015
+22% +$1.39M 0.3% 79
2019
Q1
$6.48M Buy
27,416
+1,627
+6% +$512K 0.27% 89
2018
Q4
$7.76M Buy
25,789
+4,680
+22% +$1.49M 0.36% 64
2018
Q3
$7.45M Sell
21,109
-3,236
-13% -$1.11M 0.28% 81
2018
Q2
$7.06M Hold
24,345
0.25% 107
2018
Q1
$6.66M Sell
24,345
-1,055
-4% -$327K 0.22% 113
2017
Q4
$8.09M Buy
25,400
+10,314
+68% +$3.31M 0.27% 93
2017
Q3
$4.72M Buy
15,086
+3,569
+31% +$1.06M 0.27% 92
2017
Q2
$3.12M Sell
11,517
-10,005
-46% -$2.65M 0.19% 140
2017
Q1
$5.88M Buy
+21,522
New +$6.09M 0.28% 94

Other funds holding BIIB